Maryam Javadi

Dr. Maryam Javadi


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
ERElham Razmpoosh
Elham Razmpoosh
AJAmir Javadi
Amir Javadi
HEHanieh Sadat Ejtahed
Hanieh Sadat Ejtahed
PMParvin Mirmiran
Parvin Mirmiran
MJMaryam Javadi
Maryam Javadi
AYAbbas Yousefinejad
Abbas Yousefinejad

20 February 2015 in Asian Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
AYAbbas Yavari
Abbas Yavari
MJMaryam Javadi
Maryam Javadi
PMParvin Mirmiran
Parvin Mirmiran
ZBZahra Bahadoran
Zahra Bahadoran
Context: Overproduction of reactive oxygen and nitrogen species during physical exercise, exercise induced oxidative stress and antioxidant supplementation is interesting and controversial concepts that have been considered during the past decades. Evidence Acquisition: In this review, we aimed to summarize current evidence in relation to antioxidant supplementation outcomes during exercise and physical activity. For this aim, we obtained relevant articles through searches of the Medline and PubMed databases between 1980 to 2013. Although major studies have indicated that antioxidants could attenuate biomarkers of exercise-induced oxidative stress and the use of antioxidant supplement is a common phenomenon among athletes and physically active people, there are some doubts regarding the benefits of these. Results: It seems that the best recommendations regarding antioxidants and exercise are having a balanced diet rich in natural antioxidants and phytochemicals. Conclusions: Regular consumption of various fresh fruits and vegetables, whole grains, legumes and beans, sprouts and seeds is an effective and safe way to meet all antioxidant requirements in physically active persons and athletes. Keywords: Exercise-Induced; Oxidative Stress; Reactive Oxygen Species; Vitamin C; Vitamin E; Glutathione; Antioxidant; Minerals

29 February 2016 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Verified
Journal Article
Closed access
PDF file
ALAzadeh Lesani
Azadeh Lesani
AMAsghar Mohammadpoorasl
Asghar Mohammadpoorasl
MJMaryam Javadi
Maryam Javadi
JEJabiz Modaresi Esfeh
Jabiz Modaresi Esfeh
AFAli Fakhari
Ali Fakhari

1 May 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
SMSeyedeh Fatemeh Miri
Seyedeh Fatemeh Miri
MJMaryam Javadi
Maryam Javadi
Chung-Ying LinChung-Ying Lin
Chung-Ying Lin
MGMark D. Griffiths
Mark D. Griffiths
MBMaria Björk
Maria Björk
APAmir Pakpour
Amir Pakpour

30 January 2022 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
BPBabak Pakbin
Babak Pakbin
SDShaghayegh Pishkhan Dibazar
Shaghayegh Pishkhan Dibazar
SASamaneh Allahyari
Samaneh Allahyari
MJMaryam Javadi
Maryam Javadi
ZAZahra Amani
Zahra Amani
SDSina Darzi
Sina Darzi

13 April 2022 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
FAFatemeh Ahmadian
Fatemeh Ahmadian
ERElham Razmpoosh
Elham Razmpoosh
HEHanieh-Sadat Ejtahed
Hanieh-Sadat Ejtahed
MJMaryam Javadi
Maryam Javadi
PMParvin Mirmiran
Parvin Mirmiran
FAFereidoun Azizi
Fereidoun Azizi
Background: Patients with type-2 diabetes mellitus (T2DM), have a higher risk of future cardiovascular diseases (CVD). Meanwhile, probiotics are shown to positively impact CVD-related parameters. This randomized controlled trial sought to evaluate the effects of probiotic supplementation on fundamental CVD-related parameters including atherogenic index of plasma (AIPs), blood pressure, the Framingham risk score, and antioxidant markers in patients with T2DM. Methods: Eligible participants were randomly assigned to receive 2 capsules/day of probiotics [each containing 500 mg of L.acidophilus(5 × 1010 CFU/g), L.plantarum(1.5 × 1010 CFU/g), L.fermentum(7 × 109 CFU/g), L.Gasseri(2 × 1010 CFU/g) and 38.5 mg of fructo-oligo-saccharides], or placebo for 6 weeks. Systolic and diastolic blood pressures (SBP and DBP, respectively), mean arterial blood pressure (MAP), atherogenic indices (the ratios of TC/HDL-C, LDL-C/HDL-C, and logTG/HDL-C), the 10-year Framingham CVD risk score, as well as total anti-oxidant capacity (TAC), paraoxonase (PON) and total oxidant status (TOS) were evaluated before and after the study. Final analyses were adjusted based on baseline parameters, and potential covariates including age, sex, PUFA and sodium intakes. Results: Sixty participants completed the study. Compared with placebo, probiotic supplementation resulted in a significant decrease in SBP[-9.24 mmHg(− 14.5, − 3.9)], DBP[− 3.71 mmHg(− 6.59, − 0.83)], MAP[− 5.55 mmHg(− 8.8, − 2.31)], the Framingham risk categories [medium–low(1.5) vs. 2 (medium)] and logTG/HDL-C ratio [− 0.08 (− 0.14, 0)] (All P < 0.05) at the end of the study. No significant changes were observed in the antioxidant markers. Conclusion: Overall, probiotic supplementation for 6 weeks led to a significant improvement in major CVD-related parameters in populations with T2DM, suggesting the possible beneficial role of probiotics in lowering the risk of future CVDs associated with diabetes. Nevertheless, more studies are needed to confirm the veracity of these results. Trial registration: IRCT2013100714925N1 (registered on November, 9th, 2013).